An action plan for pan-European defence against new SARS-CoV-2 variants

Affiliations

¹ Max-Planck-Institute for Dynamics and Self-Organization, 37077 Göttingen, Germany. Electronic address: viola.priesemann@ds.mpg.de.
² University of Luxembourg, Luxembourg, Luxembourg.
³ Technische Universität Braunschweig, Helmholtz Zentrum für Infektionsforschung, Braunschweig, Germany.
⁴ University Hospital, Goethe-University Frankfurt, Frankfurt, Germany.
⁵ Institute for Advanced Studies, Vienna, Austria; London School of Economics and Political Science, London, UK.
⁶ University Hospital Geneva, Geneva, Switzerland.
⁷ University of Trento, Trento, Italy.
⁸ London School of Hygiene & Tropical Medicine, London, UK; Karolinska Institute, Stockholm, Sweden.
⁹ University of Alabama at Birmingham, Birmingham, AL, USA.
¹⁰ Minerva Foundation Institute for Medical Research, Helsinki, Finland.
¹¹ Medical University of Vienna, Vienna, Austria; Complexity Science Hub Vienna, Vienna, Austria.
¹² Ludwig-Maximilian-Universität München, Munich, Germany.
¹³ ifo Institute, Leibniz Institute for Economic Research, University of Munich, Munich, Germany.
¹⁴ University of Maribor, Maribor, Slovenia; Alma Mater Europaea, Maribor, Slovenia.
¹⁵ University of Crete, Crete, Greece.
¹⁶ Department of Political Science, University of Vienna, Vienna, Austria.
¹⁷ Faculty of Mathematics, Informatics and Mechanics, University of Warsaw, Warsaw, Poland.

Viola Priesemann et al. Lancet. 2021.

. 2021 Feb 6;397(10273):469-470.

doi: 10.1016/S0140-6736(21)00150-1. Epub 2021 Jan 21.

¹ Max-Planck-Institute for Dynamics and Self-Organization, 37077 Göttingen, Germany. Electronic address: viola.priesemann@ds.mpg.de.
² University of Luxembourg, Luxembourg, Luxembourg.
³ Technische Universität Braunschweig, Helmholtz Zentrum für Infektionsforschung, Braunschweig, Germany.
⁴ University Hospital, Goethe-University Frankfurt, Frankfurt, Germany.
⁵ Institute for Advanced Studies, Vienna, Austria; London School of Economics and Political Science, London, UK.
⁶ University Hospital Geneva, Geneva, Switzerland.
⁷ University of Trento, Trento, Italy.
⁸ London School of Hygiene & Tropical Medicine, London, UK; Karolinska Institute, Stockholm, Sweden.
⁹ University of Alabama at Birmingham, Birmingham, AL, USA.
¹⁰ Minerva Foundation Institute for Medical Research, Helsinki, Finland.
¹¹ Medical University of Vienna, Vienna, Austria; Complexity Science Hub Vienna, Vienna, Austria.
¹² Ludwig-Maximilian-Universität München, Munich, Germany.
¹³ ifo Institute, Leibniz Institute for Economic Research, University of Munich, Munich, Germany.
¹⁴ University of Maribor, Maribor, Slovenia; Alma Mater Europaea, Maribor, Slovenia.
¹⁵ University of Crete, Crete, Greece.
¹⁶ Department of Political Science, University of Vienna, Vienna, Austria.
¹⁷ Faculty of Mathematics, Informatics and Mechanics, University of Warsaw, Warsaw, Poland.

No abstract available

References

1. European Centre for Disease Prevention and Control . ECDC; Stockholm: 2020. Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom. Dec 20, 2020.
1. Grove Krause T. Statens Serum Institut; Copenhagen: 2021. Ny status på forekomsten af cluster B.1.1.7 i Danmark. Jan 2, 2021.
1. Volz E, Mishra S, Chand M, et al. Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data. medRxiv. 2021 doi: 10.1101/2020.12.30.20249034. published online Jan 4. (preprint) - DOI
1. Davies NG, Barnard RC, Jarvis CI, et al. Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England. medRxiv. 2020 doi: 10.1101/2020.12.24.20248822. published online Dec 26. (preprint) - DOI
1. Callaway E. Could new COVID variants undermine vaccines? Labs scramble to find out. Jan 8, 2021. https://www.nature.com/articles/d41586-021-00031-0 - PubMed